{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:41:57Z","timestamp":1778157717090,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ygyno.2025.05.024","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T15:35:22Z","timestamp":1749742522000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study"],"prefix":"10.1016","volume":"199","author":[{"given":"Anupam","family":"Rishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin V.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Jhingran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elysia K.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyush","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Goldsberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Montejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.05.024_bb0005","series-title":"Cancer Facts & Figures 2024","author":"American Cancer Society","year":"2024"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0010","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/ijc.34655","article-title":"Global incidence, risk factors and trends of vulvar cancer: a country-based analysis of cancer registries","volume":"153","author":"Huang","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European society of gynaecological oncology guidelines for the management of patients with vulvar cancer - update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ijgc-00009577-200409000-00021","article-title":"Vulvar cancer patients\u2019 quality of life: a qualitative assessment","volume":"14","author":"Janda","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group","volume":"42","author":"Moore","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0030","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00762-8","article-title":"Preoperative chemo-radiation for carcinoma of the vulva with N2\/N3 nodes: a gynecologic oncology group study","volume":"48","author":"Montana","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0035","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/1097-0142(19841115)54:10<2056::AID-CNCR2820541003>3.0.CO;2-L","article-title":"Preoperative radiation therapy for locally advanced vulvar cancer","volume":"54","author":"Hacker","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2005.11.007","article-title":"Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome","volume":"64","author":"Beriwal","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2019.11.027","article-title":"High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: outcome and toxicity","volume":"156","author":"Rishi","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0055","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ijrobp.2012.11.012","article-title":"Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse","volume":"85","author":"Beriwal","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.adro.2017.02.006","article-title":"Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: treatment technique and outcomes","volume":"2","author":"Rao","year":"2017","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0065","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1200\/JCO.23.02235","article-title":"Phase II trial of cisplatin, gemcitabine, and intensity-modulated radiation therapy for locally advanced vulvar squamous cell carcinoma: NRG oncology\/GOG study 279","volume":"42","author":"Horowitz","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0075","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0080","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer","volume":"79","author":"Lim","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2020.09.019","article-title":"Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?","volume":"159","author":"Richman","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2018.08.002","article-title":"Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy","volume":"151","author":"Horne","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2015.09.077","article-title":"Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational study on sentinel nodes in vulvar cancer (GROINSS-V) I","volume":"140","author":"Te Grootenhuis","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0120","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.21.00006","article-title":"Radiotherapy versus Inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II","volume":"39","author":"Oonk","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2018.01.007","article-title":"Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy","volume":"148","author":"Stecklein","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1525-1438.2006.00769.x","article-title":"Squamous cell carcinoma of the vulva with bulky positive groin nodes-nodal debulking versus full groin dissection prior to radiation therapy","volume":"17","author":"Hyde","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ijgc-2022-004122","volume":"33","author":"Gien","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.05.024_bb0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/gyno.2002.6605","article-title":"Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer","volume":"85","author":"Cohn","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0145","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamaoncol.2015.6326","article-title":"Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva","volume":"2","author":"Howitt","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2025.05.024_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2022.01.029","article-title":"Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: results from the phase 2 KEYNOTE-158 study","volume":"166","author":"Shapira-Frommer","year":"2022","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825008571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825008571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:20:38Z","timestamp":1777018838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825008571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S0090825825008571"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.05.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}